NCT02397278View on ClinicalTrials.gov

Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

January 8, 2020

Study Completion Date

January 8, 2020

Conditions
Osteochondritis Dissecans
Interventions
DRUG

Platelet rich plasma (PRP)

Patient will receive 3 intra articular injections with autologous PRP in the affected knee and then follow conventional therapy.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

Terumo BCT

INDUSTRY

lead

University of Colorado, Denver

OTHER

NCT02397278 - Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee | Biotech Hunter | Biotech Hunter